Fermentalg
Fermentalg
ALGAE
EURONEXT
0.40
EUR
8.11%
About
Fermentalg SA is a France-based industrial biotechnology company. It specializes in the development of a technology which is used to produce molecules of interest and bypasses conventional methods using petrochemicals and also industrial fish farming. The Company offers a solution to the gradual depletion of two key resources: wild fish and petroleum.
The Company's technology allows it to target a range of markets, such as human nutrition, animal feed, green chemicals, cosmetics and biofuels..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 87.8K |
| Three Month Average Volume | 4.5M |
| High Low | |
| Fifty-Two Week High | 0.99 EUR |
| Fifty-Two Week Low | 0.209 EUR |
| Fifty-Two Week High Date | 05 Feb 2024 |
| Fifty-Two Week Low Date | 24 Oct 2023 |
| Price and Volume | |
| Current Price | 0.435 EUR |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 3.35% |
| Thirteen Week Relative Price Change | -21.55% |
| Twenty-Six Week Relative Price Change | -18.74% |
| Fifty-Two Week Relative Price Change | -33.05% |
| Year-to-Date Relative Price Change | 42.09% |
| Price Change | |
| One Day Price Change | -1.14% |
| Thirteen Week Price Change | -25.00% |
| Twenty-Six Week Price Change | -21.90% |
| Five Day Price Change | -0.68% |
| Fifty-Two Week Price Change | -29.84% |
| Year-to-Date Price Change | 44.04% |
| Month-to-Date Price Change | -1.14% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 0.60325 EUR |
| Book Value Per Share (Most Recent Quarter) | 0.60325 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.31011 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.31011 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.18813 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.09172 EUR |
| Revenue Per Share (Trailing Twelve Months) | 0.09172 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 EUR |
| Dividend Per Share (Trailing Twelve Months) | 0 EUR |
| Dividend Per Share (5 Year) | -99999.99 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.31979 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.31764 EUR |
| Normalized (Last Fiscal Year) | -0.31186 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.31979 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.31764 EUR |
| Including Extraordinary Items (Last Fiscal Year) | -0.31979 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | -0.31764 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.21829 EUR |
| Cash Per Share (Most Recent Quarter) | 0.21829 EUR |
| Cash Flow Per Share (Last Fiscal Year) | -0.22918 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | -0.22918 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.20646 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -216 |
| Cash Flow Revenue (Trailing Twelve Months) | -225 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -327.08% |
| Pretax Margin (Last Fiscal Year) | -327.08% |
| Pretax Margin (5 Year) | -233.86% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 13.21% |
| Gross Margin (Trailing Twelve Months) | 13.21% |
| Gross Margin (5 Year) | 14.73% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -290.98% |
| Operating Margin (Trailing Twelve Months) | -290.98% |
| Operating Margin (5 Year) | -216.76% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -327.08% |
| Net Profit Margin (Trailing Twelve Months) | -327.08% |
| Net Profit Margin (5 Year) | -248.95% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -21.38% |
| Tangible Book Value (5 Year) | -7.45% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -28.62% |
| Revenue Growth (3 Year) | 75.18% |
| Revenue Change (Trailing Twelve Months) | -46.94% |
| Revenue Per Share Growth | 44.92% |
| Revenue Growth (5 Year) | 22.55% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -10.93% |
| Total Debt (5 Year) | 12.92% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -73.35% |
| EPS Change (Trailing Twelve Months) | -33.03% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 2 |
| Price to Tangible Book (Most Recent Quarter) | 2 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 4.2M |
| Net Debt (Last Fiscal Year) | 4.2M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 9 |
| Price to Sales (Trailing Twelve Months) | 9 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 46 |
| Long Term Debt to Equity (Most Recent Quarter) | 46 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 4 |
| Quick Ratio (Most Recent Quarter) | 4 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 5 |
| Current Ratio (Most Recent Quarter) | 5 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -9,134,000 |
| Free Cash Flow (Trailing Twelve Months) | -9,134,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -61 |
| Net Interest Coverage (Trailing Twelve Months) | -61 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 50 |
| Total Debt to Equity (Most Recent Quarter) | 50 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -24.63% |
| Return on Assets (Trailing Twelve Months) | -24.63% |
| Return on Assets (5 Year) | -21.94% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -38.85% |
| Return on Equity (Trailing Twelve Months) | -38.85% |
| Return on Equity (5 Year) | -34.31% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -26.79% |
| Return on Investment (Trailing Twelve Months) | -26.79% |
| Return on Investment (5 Year) | -24.71% |